Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantation
- Ho Sup Lee
- , Yang Soo Kim
- , Kihyun Kim
- , Jin Seok Kim
- , Hyo Jung Kim
- , Chang Ki Min
- , Cheolwon Suh
- , Hyeon Seok Eom
- , Sung Soo Yoon
- , Jae Hoon Lee
- , Min Kyong Kim
- , Sung Hyun Kim
- , Sung Hwa Bae
- , Yeung Chul Mun
- , Deog Yeon Jo
- , Joo Seop Chung
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations